je.st
news
Epizyme: The Ugly Duckling Of The 2014 Biotech Rally?
2015-01-02 17:10:52| Biotech - Topix.net
When I analyzed Epizyme a year ago , I argued that Epizyme represents a promising early biotech company developing novel small molecule inhibitors targeting specific epigenome modifying mutations. After a precipitous drop of the stock price in November, the stock was a no-brainer for me.
Tags: rally
ugly
biotech
duckling
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||